Adam Mence from L&R Medical UK explains how the company is empowering patients to manage their conditions while supporting NHS goals for improving care outcomes and efficiency. Overall, investing in self-care and innovative technologies is shown to be both clinically effective and cost-efficient.
Latest study shows people may be able to reduce their risk of atrial fibrillation by avoiding certain triggers like alcohol, in consideration of other lifestyle factors.
Afshin Attari, Senior Director of Public Sector & Unified Platforms at Exponential-e, describes driving the digital-first future of pathology through partnerships.
Doris-Ann Williams MBE, CEO, BIVDA, calls for increased community testing as a way to clear the NHS backlog and deal with the increasing number of people who are living with undiagnosed diseases in the UK.
Professor Carlos Aguiar, Chair of the European Society of Cardiology (ESC) Communication Committee and spokesperson for Heart Failure, outlines the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
Captain Casey Barton Behravesh of the U.S. Public Health Service, and Director of the CDC One Health Office highlights the CDC’s efforts to nationally and internationally prevent zoonotic diseases.
Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.
Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
Chief Executive of the Huntington’s Disease Association, Cath Stanley, maps out the charities ongoing work to support its community, despite the COVID-19 pandemic.
